Remove 2020 Remove Competition Remove Doctors
article thumbnail

The Top 10 Medical Device Success Podcasts in 2020!

Medical Device Success

35 podcasts were produced in our inaugural year of 2020. 1 Ep 4 – The Future of the Medical Device Industry in the Covid-19 Era, April 12, 2020. 2 Ep 6 – Selling in a Covid-19 Word – New Sales Practices, April 26, 2020. 3 Ep 10 – The Reopening, Covid-19 and what it means for Medical Devices, May 24, 2020.

Medical 100
article thumbnail

3 Insights From Re:Imagine Pharma Marketing 2020

Pharma Marketing Network

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. Pharma Marketing 2020: The Enduring Impact . Rea ching HCP’s When Your Sales Force Can’t.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma’s reputational high will be short-lived

World of DTC Marketing

Big Pharma’s reputation has been down in the dumps for years, after a series of scandals involving Medicare fraud, improper payments to doctors, and poorly tested drugs that damaged health. Pharma has gone to court again and again to delay generic competition of biologic drugs. In fact, Richard Gonzalez, C.E.O.

Pharma 186
article thumbnail

Episode 28 – A CEO Leading a MedTech Company Through Covid

Medical Device Success

Reading time: 2 – 3 minutes In January 2018 when Dominik Beck took the helm of Rudolf Riester, GmbH, he began executing a plan to put Riester in a more competitive position against its larger rivals. Then in early 2020 Covid spread across the world. Then in early 2020 Covid spread across the world. Now Go Win Your Week!

Leads 100
article thumbnail

Pandemic Innovators: Pharma Marketing Strategies that Reinvent the In-Person Conversation

Pharmaceutical Representative Training

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.

article thumbnail

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

However, this picture of recovery hides a less positive trend – non-COVID innovative launches from 2020 onwards, have, with certain exceptions, under-performed pre-pandemic benchmarks of launch sales performance in the major countries in the market – that is, the US, EU4+UK, China and Japan. The scope of the problem.

Doctors 59
article thumbnail

How to Adapt Your Marketing Now That Private Practice Has Become an “Endangered Species”

Healthcare Success

At the end of 2020—for the first time ever—less than half ( 49.1% ) of patient care physicians worked in private practice. . According to Avalere Health , nearly three in four doctors work for a hospital, health system, or corporate entity today. of doctors ages 40-54 and just 30% of physicians under the age of 40.